Stay updated on Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.

Latest updates to the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 with no changes to page content or functionality; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1; this maintenance change does not affect study content or available actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedGlossary controls were added (Show/Hide glossary) and the footer now includes 'Last Update Submitted that Met QC Criteria' with Revision: v3.4.0. Older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.3%

- Check40 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. There are no changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedLocations section added with Georgia; HHS Vulnerability Disclosure and Georgia Locations labels removed; revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check90 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.